Table 1.
Clinical data for study patients
| Patient # | Age | Gender | Lyme serology | Coinfecting tickborne diseases | Antibiotic treatment |
|---|---|---|---|---|---|
| 1 | 86 | Female | Positive | Babesia microti, Bartonella henselae | Treated at time of sampling |
| 2 | 52 | Female | Positive |
Ehrlichia chaffeensis,
Anaplasma phagocytophilum |
Previous treatment, but off at time of study |
| 3 | 56 | Female | *Positive | Not tested | Never treated |
| 4 | 75 | Female | *Positive | Not tested | Not treated at time of study |
| 5 | 50 | Male | Equivocal | Not tested | Never treated |
| 6 | 41 | Male | Positive | Spotted fever group and typhus fever group | Began treatment after start of study |
| 7 | 51 | Female | *Positive | Not tested | Never treated |
| 8 | 53 | Female | Positive | Not tested | Previous treatment, but off at time of study |
| 9 | 35 | Female | Not tested | Not tested | Never treated |
| 10 | 63 | Female | Positive | Spotted fever group and Mycoplasma spp. (Labcorp) | Not treated at time of study |
| 11 | 47 | Female | *Positive | Not tested | Not treated at time of study |
| 12 | 38 | Male | Positive | None | On antibiotic therapy during study |
| 13 | 43 | Female | Positive | Babesia spp. | Treated but off antibiotics during study |
| 14 | 53 | Female | *Positive | Not tested | Never treated |
| 15 | 48 | Female | Clinical diagnosis, not tested | Not tested | Not treated at time of study |
| 16 | 56 | Female | Not tested | Not tested | Never treated |
| 17 | 62 | Female | *Positive | Not tested | Not treated at time of study |
| 18 | 51 | Female | Not tested | Not tested | Never treated |
| 19 | 75 | Female | **Positive | Not tested | Had 2 weeks treatment for Lyme but no treatment after |
| 20 | 60 | Female | **Positive | Not tested | Had 3 weeks erythromycin after EM rash and + serology, no treatment after |
| 21 | 37 | Female | Positive | Not tested | Not treated at time of study |
| 22 | 53 | Female | Not tested | Not tested | Not treated at time of study |
| 23 | 68 | Female | Not tested | Not tested | Never treated |
| 24 | 73 | Female | Not tested | Not tested | Never treated |
| 25 | 58 | Female | ***Positive | Not tested | Never treated |
All Lyme serology except that of patients 19, 20, and 25 tested and interpreted by IGeneX Reference Laboratories, Palo Alto, CA [10].
*Tested for B. burgdorferi after skin sampling was taken for study.
**Positive by 2-tiered CDC surveillance criteria.
***Tested by Spectracell Laboratories, Houston, TX.